Tag: ACC 2017
ACC 2017: Dual anti-thrombotic approach has similar risk of bleeding to dual antiplatelet therapy
The GEMINI-ACS study,...
Viagra may reduce cardiovascular outcomes after a first myocardial infarction
Daniel P Andersson (D...
ACC 2017: Meta-analysis supports use of RenalGuard in cardiovascular Interventional procedures
A new meta-analysis p...
ACC 2017: Positive final results from ORION-1 phase II study of inclisiran
The Medicines Company and...
ACC 2017: TAVI Linked with bleeding in the brain and neurological impairment
Of 84 older patients ...
ACC 2017: Embol-X and CardioGard do not reduce number of brain lesions, but may affect lesion size
Two US Food and Drug Admi...
ACC 2017: “iFR may be the new standard” of physiological assessment of coronary lesions
Writing in The New En...
ACC 2017: Mary Norine Walsh assumes American College of Cardiology presidency
Mary Norine Walsh has...
ACC 2017: Wrist-worn heart rate monitors less accurate than standard chest strap
Researchers at Cleveland ...
ACC 2017: Researchers sound alarm over Zika’s potentially harmful effects on heart
As the Zika virus con...
ACC 2017: CardioMEMS HF system effective in reducing heart failure hospitalisations and cost of care
Late-breaking clinica...
ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular events
Data for a new drug t...
ACC 2017: Two-year rate of target lesion failure significantly higher with Absorb
Two-year data from th...
